Osteoporosis: Gender-specific aspects

Wiener Medizinische Wochenschrift

Volumn 154, Issue 17-18, 2004, Pages 411-415

  Pietschmann, Peter ^a,b   Kerschan Schindl, Katharina ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Gender; Idiopathic osteoporosis; Osteoporosis; Osteoporosis in men; Postmenopausal osteoporosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; CORTICOSTEROID; ESTRADIOL; ESTROGEN; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID;

BONE DENSITY; BONE FRAGILITY; BONE STRENGTH; CORTICOSTEROID INDUCED OSTEOPOROSIS; DISEASE CLASSIFICATION; ESTROGEN DEFICIENCY; FOREARM FRACTURE; HIP FRACTURE; HUMAN; IDIOPATHIC OSTEOPOROSIS; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; SECONDARY HYPERPARATHYROIDISM; SEX DIFFERENCE; THYROTOXICOSIS; VERTEBRA FRACTURE; VITAMIN D DEFICIENCY;

ADULT; AGED; CLINICAL TRIALS; DIPHOSPHONATES; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS; SEX FACTORS;

EID: 7044260921     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-004-0100-1     Document Type: Review

References (44)

1. Anonymous (2001) Osteoporosis prevention, diagnosis and therapy. JAMA 285: 785-795
2. Melton LJ, Chrischilles EA, Lane AW, Riggs BL (1992) Perspective. How many women have osteoporosis? J Bone Miner Res 7: 1005-1010
3. O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European vertebral osteoporosis study. J Bone Miner Res 11: 1010-1018
4. Jackson SA, Tenenhouse A, Robertson L (2000) Vertebral fracture definition from population-based data: preliminary results from the Canadian multicenter osteoporosis study. Osteoporos Int 11: 680-687
5. Koeck CM, Schwappach DLB, Niemann FM, Strassmann TJ, Ebner H, Klaushofer K (2001) Incidence and costs of osteoporosis-associated hip fractures in Austria. Wien Klin Wochenschr 113: 371-377
6. Cree M, Soskolne CL, Belseck E, Hornig J, McElhaney JE, Brant R, Suarez-Almazor M (2000) Mortality and institutionalization following hip fracture. JAGS 48: 283-288
7. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9: 1137-1141
8. Pietschmann P, Peterlik M (1999) Pathophysiologie der Osteoporose. Wien Med Wochenschr 149: 454-462
9. Bartl R (2001) Osteoporose. Georg Thieme, Stuttgart, S 1-21
10. Seeman E (2002) Pathogenesis of bone fragility in women and men. Lancet 359: 1841-1850
11. Seeman E, Melton LJ, O'Fallon WM, Riggs BL (1983) Risk factors for spinal osteoporosis in men. Am J Med 75: 977-983
12. Resch H, Pietschmann P, Woloszczuk W, Krexner E, Bernecker P, Willvonseder R (1992) Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis. Eur J Clin Invest 22: 542-545
13. Baillie S, Davidson CE, Johnson FJ, Francis RM (1992) Pathogenesis of vertebral crush fractures in men. Age Ageing 21: 139-141
14. Kelepoulis N, Harper KD, Gannon F, Kaplan FS, Haddad JG (1995) Severe osteoporosis in men. Ann Intern Med 123: 452-460
15. Graninger M, Dirnberger E, Kainberger F, Bernecker P, Graninger W, Smolen J, Pietschmann P (1995) Comparison of spinal and femoral dual energy X-ray absorptiometry (DXA) in men with primary and secondary osteoporosis. Osteologie 7: 48-52
16. Ringe JD, Dorst AJ, Faber H (1997) Osteoporosis in men - Clinical assessment of 400 patients and 205 controls by risk factor analysis, densitometry, and X-ray findings. Osteologie 6: 81-86
17. Cakir B, Odabasi E, Turan M, Guler S, Kutlu M (2002) Secondary osteoporosis in women. A retrospective analysis. Arch Gynecol Obstet 266: 214-217
18. Riggs BL, Melton LJ III (1983) evidence for two distinct syndromes of involutional osteoporosis. Am J Med 75: 899-901
19. Riggs BL, Khosla S, Melton LJ III (1998) A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13: 763-773
20. Schiller C, Gruber R, Redlich K, Ho GM, Katzgraber F, Willheim M, Pietschmann P, Peterlik M (1997) 17β-Estradiol antagonizes effects of 1a,25- dihydroxyvitamin D3 on interleukin-6 production and osteoclast-like cell formation in mouse bone marrow primary cultures. Endocrinology 138: 4567-4571
21. Oursler MJ, Osodoby P, Pyfferoen J, Riggs PL, Spelsberg TC (1991) Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 88: 6613-6617
22. Prince R, Dick I, Devine A, Price R, Gutteridge D, Kerr D, Criddle A, Garcia-Webb P, St John A (1995) The effects of menopause and age on calcitropic hormones: a cross-sectional study of 655 healthy women aged 35-90. J Bone Miner Res 10: 835-842
23. Heaney RP, Recker RR, Saville PD (1978) Menopausal changes in calcium balance performance. J Lab Clin Med 92: 953-963
24. Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ (1989) Castrated men exhibit bone loss; effect of cacitonin treatment on biochemical indices of bone remodelling. J Clin Endocrinol Metab 69: 523-527
25. Feldman HA, Longcope C, Derby CA, Johannes CA, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87: 589-598
26. Pietschmann P, Gollob E, Brosch S, Hahn P, Kudlacek S, Willheim M, Woloszczuk W, Peterlik M, Tragl KH (2003) The effect of age and gender on cytokine production by human peripheral blood mononuclear cells and markers of bone metabolism. Exp Gerontol 38: 1119-1127
27. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubhahn DB, Korach KS (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in man. N Engl J Med 331: 1056-1061
28. Khosla S, Melton LJ III, Riggs BL (2001) Estrogens and bone health in men. Calcif Tissue Int 69: 189-192
29. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S (2000) Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106: 1553-1560
30. Gillberg P, Johansson AG, Ljunghall S (1999) Decreased estradiol levels and free androgen index and elevated sex hormone-binding globulin levels in male idiopathic osteoporosis. Calcif Tissue Int 64: 209-213
31. Carlsen CG, Soerensen TH, Eriksen EF (2000) Prevalence of low serum estradiol levels in male osteoporosis. Osteoporos Int 11: 697-701
32. Pietschmann P, Kudlacek S, Grisar J, Spitzauer S, Woloszczuk W, Willvonseder R, Peterlik M (2001) Bone turnover markers and sex hormones in men with idiopathic osteoporosis. Eur J Clin Invest 31: 444-451
33. Legrand E, Hedde C, Gallois Y, Degasne I, Boux de Casson F, Mathieu E, Basle MF, Chappard D, Audran M (2001) Osteoporosis in men: a potential role for the sex hormone binding globulin. Bone 29: 90-95
34. Evans SF, Davie MWJ (2002) Low body size elevated sex-hormone binding globuline distinguish men with idiopatic vertebral fracture. Calcif Tissue Int 70: 9-15
35. Wendlova J, Mikulecky M (2001) Determination of NTx in second morning urine: a proposal for the standardization of morning urine collection. Wien Med Wochenschr 151: 472-475
36. Khosla S, Melton LJ, Atkinson EJ, O'Fallon WM, Klee GG, Riggs L (1998) Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 83: 2266-2274
37. Souberbielle JC, Cormier C, Kindermans C, Gao P, Cantor T, Forette F, Baulieu EE (2001) Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 6: 3086-3090
38. Visser M, Deeg DJ, Lips P (2003) Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcoepenia): the longitudinal aging study Amsterdam. J Clin Endocrinol Metab 88: 5766-5772
39. Dimai HP, Pietschmann P, Resch H, Klaushofer K (2002) Leitfaden zur medikamentösen Therapie der postmenopausalen Osteoporose. Wien Med Wochenschr 152: 596-612
40. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344: 1434-1441
41. Resch H, Gollob E, Kudlacek S, Pietschmann P (2001) Die Osteoporose beim Mann. Wien Med Wochenschr 151: 457-463
42. Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343: 604-610
43. Ringe JD, Faber H, Dorst A (2001) Alendronate treatment of established primary osteoporosis in men: results from a 2-year prospective study. J Clin Endocrinol Metab 86: 5252-5255
44. Orwoll ES, Scheele WH, Paul S, Adami S, Syversen U, Diez-Perez A, Kaufman JM, Clancy AD, Gaich GA (2003) The effect of teriparatide [Human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res 18: 9-17